United States · FDA National Drug Code directory
Clobazam
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 42571-316_50d350cb-6640-b3c2-e063-6394a90a397b
- Product NDC
- 42571-316
- Form
- TABLET
- Composition / generic term
- Clobazam
- Labeler
- Micro Labs Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190402
- Source listing expiry
- 20271231
Source-listed ingredients
- CLOBAZAM — 20 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (42571-316-01) · 42571-316-01
- 100 BLISTER PACK in 1 CARTON (42571-316-11) / 10 TABLET in 1 BLISTER PACK (42571-316-32) · 42571-316-11
- 30 TABLET in 1 BOTTLE (42571-316-30) · 42571-316-30
- 90 TABLET in 1 BOTTLE (42571-316-90) · 42571-316-90
- 100 BLISTER PACK in 1 CARTON (42571-316-91) / 10 TABLET in 1 BLISTER PACK (42571-316-20) · 42571-316-91
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →